![Stanford Peng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stanford Peng
Inversor de Capital Privado en
Frazier Management LLC
.
Perfil
Stanford L.
Peng is currently a Venture Partner at Frazier Management LLC since 2025.
Former positions include President, Head-Research & Development at Alpine Immune Sciences, Inc. from 2019 to 2024; Chief Medical Officer & Head-Clinical Development at Stemcentrx, Inc. from 2015 to 2016; Executive Director-Medical at Seagen, Inc. from 2014 to 2015; Head-Rheumatology Clinical Research Unit at Benaroya Research Institute at Virginia Mason from 2009 to 2014; Senior Director at ARYx Therapeutics, Inc. from 2008 to 2009; and Assistant Professor at Washington University School of Medicine from 2002 to 2005.
Education includes undergraduate studies at Stanford University and a doctorate from Yale School of Medicine.
Cargos activos de Stanford Peng
| Empresas | Cargo | Inicio |
|---|---|---|
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Inversor de Capital Privado | 01/01/2025 |
Antiguos cargos conocidos de Stanford Peng.
| Empresas | Cargo | Fin |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Presidente | 20/05/2024 |
Stemcentrx, Inc.
 Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Director Técnico/Científico/I+D | 01/01/2016 |
| SEAGEN INC. | Director Técnico/Científico/I+D | 01/01/2015 |
Benaroya Research Institute at Virginia Mason
 Benaroya Research Institute at Virginia Mason Miscellaneous Commercial ServicesCommercial Services Operates medical research institute for autoimmune and immune system diseases | Director Técnico/Científico/I+D | 01/01/2014 |
| ARYX THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/01/2009 |
Formación de Stanford Peng.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
37
Relaciones de 1er grado
9
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 9 |
|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Finance |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARYx Therapeutics, Inc.
 ARYx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Benaroya Research Institute at Virginia Mason
Benaroya Research Institute at Virginia Mason Miscellaneous Commercial ServicesCommercial Services Operates medical research institute for autoimmune and immune system diseases | Commercial Services |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
- Bolsa de valores
- Insiders
- Stanford Peng
